(Q28284829)

1

0 references

D Roulot

2

0 references

G Pelletier

3

0 references

E A Pariente

4

0 references

J Denis

5

0 references

O Ink

6

0 references

P Blanc

7

0 references

J P Richardet

8

0 references

J P Vinel

9

0 references

F Delisle

10

0 references

D Fischer

11

0 references

X Amiot

Spontaneous bacterial peritonitis

13

0 references

language of work or name

English

0 references

publication date

September 1998

0 references

published in

Journal of Hepatology

0 references

volume

29

0 references

issue

3

0 references

page(s)

430-6

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980061-5

7 January 2021

Amoxicillin-clavulanic acid therapy of spontaneous bacterial peritonitis: a prospective study of twenty-seven cases in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980061-5

7 January 2021

Survival after a first episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980061-5

7 January 2021

Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980061-5

7 January 2021

Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980061-5

7 January 2021

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980061-5

7 January 2021

Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980061-5

7 January 2021

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980061-5

7 January 2021

Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: Relevance of ascitic fluid protein concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980061-5

7 January 2021

Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980061-5

7 January 2021

Selective intestinal decontamination prevents spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980061-5

7 January 2021

Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980061-5

7 January 2021

Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980061-5

7 January 2021

Culture-negative neutrocytic ascites: a less severe variant of spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980061-5

7 January 2021

10.1016/S0168-8278(98)80061-5

Identifiers

DOI

0 references

Fatcat ID

release_kdqa2oaxarcq3kvb7diuuypok4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kdqa2oaxarcq3kvb7diuuypok4

24 November 2022